▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Dan Carroll

TMFCane

Dan began writing for the Motley Fool in 2012. He is a health care specialist who also follows the defense industry along with tracking the broader U.S. and international markets.

Recent Articles by Dan Carroll

May 28, 2014 by Dan Carroll

Intel Powers Higher on a Downbeat Day for the Dow

Valeant Pharmaceuticals and Allergan shares both sink as a new development emerges in their ongoing acquisition battle.

May 27, 2014 by Dan Carroll

American Express' Surge Pushes the Dow Higher

IBM's stock tumbles on renewed concerns from China.

May 23, 2014 by Dan Carroll

Why Pharmacyclics, Inc., Matador Resources Co, and Twitter Inc Are Today's 3 Worst Stocks

Despite a good day from the market that saw the S&P 500 close higher than 1,900, these three stocks took a tumble and disappointed investors

May 23, 2014 by Dan Carroll

DuPont's Gains Push the Dow's Week-Ending Climb

Pfizer falls to the bottom of the Dow as investors move on from the company's failed attempts to lure AstraZeneca.

May 23, 2014 by Dan Carroll

Nike's Stock Sprints Ahead to Lead an Upbeat Dow

Earnings help Hewlett-Packard's stock roar higher by more than 6% after another significant round of layoffs pushes hope that the company's turnaround will maintain momentum.

May 22, 2014 by Dan Carroll

Johnson & Johnson Keeps the Dow's Momentum on Track as Microsoft's Stock Slips

China's manufacturing sector can't dig out of contraction despite an upbeat and expectations-toppin result that kicked off a cautiously optimistic day for the Dow.

May 21, 2014 by Dan Carroll

Medtronic's Earnings: 3 Things You Need to Know

Med tech's biggest player settled a long-running headache in its most recent quarter, but it's not the only reason investors should be optimistic about Medtronic's direction

May 21, 2014 by Dan Carroll

Verizon Powers Up the Dow's Triple-Digit Surge

Verizon's stock climbs on a strong day for blue chippers while Target's stock overcomes earnings woes.

May 21, 2014 by Dan Carroll

Can Abbott Laboratories Breathe Life into This Struggling Business?

Abbott's generics business has seen falling sales as of late, but the company's hoping a big splash overseas can deliver a windfall.

May 20, 2014 by Dan Carroll

Is Bristol-Myers Squibb's Dividend Unbeatable?

Big pharma's home to many great dividends, but is Bristol-Myers Squibb's yield the best bet for your money?

May 15, 2014 by Dan Carroll

Why the National Bank of Greece, Alliant Techsystems Inc., and Bristol-Myers Squibb Co Are Today's 3 Worst Stocks

Three leading names take big hits on what turned out to be a horrid day for investors, as Bristol-Myers, National Bank of Greece, and Alliant Techsystems all fall in big ways

May 15, 2014 by Dan Carroll

Can St. Jude Medical Inc. Win This Crucial Market?

The transcatheter aortic valve replacement market has attracted a lot of attention around the device industry, and St. Jude's not wasting time looking for its share of the opportunity.

May 15, 2014 by Dan Carroll

The Dow Tanks 167 Points as JC Penney Explodes in After-Hours Trading

Cisco manages a 6% gain despite the Dow's drop, but the market ended up on a downbeat note despite the tech giant's improved earnings

May 15, 2014 by Dan Carroll

Cisco's Earnings Bounce Can't Prevent the Dow's Triple-Digit Slide

Wal-Mart's earnings loss are only part of a terrible day around the market.

May 14, 2014 by Dan Carroll

IBM Leads the Dow's Downturn as Sony, Deere Feel Earnings Pain

A bad day from the Dow comes after IBM falls hard despite projecting hardware industry stability in 2014.

May 13, 2014 by Dan Carroll

Coca-Cola, Merck Lead the Way for the Dow's Gain

Home Depot sinks to the bottom of the index on a wobbly day for stocks around the market.

May 13, 2014 by Dan Carroll

3 Reasons to Buy the Market's Biggest Health Insurer

The Affordable Care Act's shaking up the health insurance landscape, but UnitedHealth's looking forward to a bright future regardless.

May 13, 2014 by Dan Carroll

Is GlaxoSmithKline's Dividend Unbeatable?

GlaxoSmithKline offers one of the highest-yielding dividends in big pharma, but does that make this stock a good bet in the long run?

May 13, 2014 by Dan Carroll

3 Key Trends Determining Pfizer's Future

As Pfizer struggles to jumpstart growth, keep an eye on three leading trends that could make or break this big pharma's future.

May 12, 2014 by Dan Carroll

Cisco Powers Up as Dow Races to Hundred-Point Gain

Hillshire Farms takes a tumble after the announcement of the company's intended acquisition of Pinnacle Foods

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services